HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plandai Phytofare In NutriBullet: Health And Wellness Industry News Roundup

This article was originally published in The Rose Sheet

Executive Summary

CHPA appoints former Mylan executive Marc Schloss head of federal government affairs; Cran-Max maker touts cranberry UTI benefits; Celsius energy drinks expand into Asia; and more news in brief.

You may also be interested in...



Regulatory Problems Mount For Supplement Firm Following Recall

in addition to distributing supplements containing ED ingredients, MS Bionic was in violation of an extensive list of supplement GMP regulations. Meanwhile Absonutrix makes claims for its herbals and botanicals including "aids in the inhibition of colon cancer cell growth and survival."

Cranberry As UTI Prevention Gets No Support In JAMA Study, Commentary

Researchers should look for remedy other than cranberry for preventing UTIs, according to an editorial on findings from a Yale study that found two cranberry capsules daily in older women did not prevent UTIs.

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108722

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel